Alberto F. Ocana
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 206 publications
Correction to: Rational design of lipid-based nanoparticles for targeted anticancer therapies.
Journal: Drug delivery and translational research
Published: April 23, 2026
Corrigendum to "Antitumoral activity of a CDK12 inhibitor in colorectal cancer through a liposomal formulation" [Biomed. Pharmacother. 178 (2024) 117165].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 22, 2026
Comparative Assessment of Free Energy Computational Methods for Revealing the Interactions Driving PARP1 Selective Inhibition.
Journal: Journal of chemical information and modeling
Published: April 18, 2026
From trial-and-error to inverse design: how AI is redefining drug delivery systems.
Journal: Drug discovery today
Published: February 17, 2026
Tumor-type specific methylation patterns of MTAP in human samples and cell lines.
Journal: Clinical epigenetics
Published: January 17, 2026
Cooperative molecular interaction networks govern PARP1 inhibitor selectivity and binding affinity.
Journal: PLoS computational biology
Published: January 16, 2026
Rational design of lipid-based nanoparticles for targeted anticancer therapies.
Journal: Drug delivery and translational research
Published: January 12, 2026
Guanidine-Based Ligands in Bioinorganic Chemistry: Coordination Modes and Applications in Anticancer Metallodrugs.
Journal: Bioinorganic chemistry and applications
Published: January 08, 2026
Nanotechnology-based approaches for head and neck cancer treatment.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 08, 2025
PROTAC delivery systems: Innovative approaches for cancer treatment.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 27, 2025
Last Updated: 09/26/2026